FDA Approves Astellas'' Vaprisol® For Treatment Of Euvolemic Hyponatremia

... Astellas Pharma US, Inc announced that the U.S. Food and Drug Administration (FDA) has approved VAPRISOL® (investigational name: YM087, generic name: conivaptan hydrochloride injection), an arginine vasopressin (AVP) antagonist for the intravenous treatment of euvolemic hyponatremia in hospitalized patients... click link for more info. ...